What is Evolugate?
Evolugate is at the forefront of bio-industrial efficiency, utilizing a sophisticated platform centered on evolutionary strain optimization. The company's commitment to scientific advancement is evident through its involvement in research publications and its active initiatives targeting critical areas such as COVID-19 and vaccine development. By providing cutting-edge solutions, Evolugate aims to significantly enhance productivity for its clientele within the biotechnology and broader industrial markets. Its operations are strategically located in Gainesville, Florida.
How much funding has Evolugate raised?
Evolugate has raised a total of $116K across 1 funding round:
Debt
$116K
Debt (2021): $116K with participation from PPP
Key Investors in Evolugate
PPP
Public-Private Partnership
What's next for Evolugate?
The recent major strategic investment, as part of Evolugate's large-scale late-stage funding, signals a pivotal moment for the company's growth trajectory. This capital infusion is expected to accelerate the scaling of its bio-industrial solutions, enabling broader market penetration and potentially funding further research and development into advanced biotechnologies. The strategic nature of this financing suggests a focus on consolidating market position and preparing for future expansion phases, possibly through strategic partnerships or further acquisitions.
See full Evolugate company page
